Neil H. Goldstein Sign in to save

OpenAlex Aachen author

Currently: Janssen (Netherlands)

2.39k

Citations

h-index

i10-index

Patent citations

Works (all)

Aachen papers

Departments & institutes in Aachen

Janssen Vaccines & Prevention BV Janssen (Netherlands)

3 papers · 2020–2021
Janssen Vaccines & Prevention B.V Janssen (Netherlands)

2 papers · 2021–2024
Janssen Infectious Diseases and Vaccines Janssen (Netherlands)

2 papers · 2020–2022

Affiliations exactly as printed on papers (7)

2× Janssen Vaccines and Prevention BV, Leiden, Netherlands
1× Janssen Vaccines & Prevention BV, Leiden, Netherlands
1× Janssen Infectious Diseases and Vaccines , Leiden , the Netherlands
1× Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands
1× Janssen Vaccines & Prevention B.V
1× Janssen Vaccines & Prevention B.V, Leiden, The Netherlands
1× Janssen Vaccines & Prevention B.V., Leiden, The Netherlands

Papers 7 stored

All · Aachen affiliation only

Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial
2024 Human Vaccines & Immunotherapeutics article Medicine Viral Infections and Outbreaks Research Open access cited by 2 patents

8

citations
First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study
2022 PLoS ONE article Medicine Viral Infections and Outbreaks Research Open access

34

citations
Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen
2021 npj Vaccines article Medicine Viral Infections and Outbreaks Research Open access

10

citations
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
2021 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access

96

citations
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
2021 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 2 patents

94

citations
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial
2020 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 7 patents

173

citations
Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study
2020 The Journal of Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access

41

citations

7 results

Neil H. Goldstein ▲ Sign in to save

Departments & institutes in Aachen

Papers 7 stored

Neil H. Goldstein Sign in to save